BC Innovations | Nov 27, 2017
Distillery Therapeutics

Endocrine / Metabolic

INDICATION: Obesity Patient sample and mouse studies suggest inhibiting MKK6 could help prevent obesity. In obese patients, MKK6 expression was higher in white adipose tissue (WAT) than in WAT from non-obese individuals. In obese mice...
BC Innovations | Aug 6, 2009
Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Bladder cancer Jun oncogene (JUN); mitogen-activated protein kinase kinase 6 (MAP2K6); signal transducer and activator of transcription 3 (STAT3); intercellular adhesion molecule-1 (ICAM-1; CD54) Studies...
Items per page:
1 - 2 of 2